Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Diversity
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
PipCast®
PTE
Trade Marks
Webinars

Novo Nordisk Announce 2023 Financial Results in Annual Report

Jan 31, 2024

Novo Nordisk announced in its 2023 Annual Report that it has increased sales by 31% to DKK 232.3B in 2023, and increased its operating profit by 37% in Danish Kroner.  Key developments outlined in the Report include:

  • a 51% net profit increase and 49% increase in share price;
  • a total of DKK75B investment in expanding global production sites in 2023;
  • 40.5M people accessed Novo Nordisk’s diabetes care products;
  • a summary of the SELECT trial which showed cardiovascular benefits of semaglutide, including a 20% reduction in major adverse cardiovascular events compared to a placebo; and
  • an update on Novo Nordisk’s once-weekly insulin product (Insulin icodec).